Ekso Bionics Plans 510(k) For Robotic Exoskeleton Based On FDA Class II Designation
This article was originally published in The Gray Sheet
Executive Summary
The firm will submit a 510(k) later this month for its Ekso GT robotic skeleton, currently being marketed as a class I exempt device, based on feedback from FDA that robotic exoskeleton devices need to meet class II requirements.
You may also be interested in...
Argo Medical And Ekso Bionics Make Strides With Robotic Walking Devices
Two emerging companies – Argo Medical Technologies Inc. and Ekso Bionics Inc. – are making substantial headway with robotic devices designed to help paralyzed patients regain the ability to walk.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.